Analytical Method Development: Refractive Index Method Development – V 2.0
SOP for Development of Refractive Index Method in Analytical Method Development Laboratory
Department |
Analytical Method Development |
SOP No. |
SOP/AMD/065/2025 |
Supersedes |
SOP/AMD/065/2022 |
Page No. |
Page 1 of 14 |
Issue Date |
19/05/2025 |
Effective Date |
20/05/2025 |
Review Date |
19/05/2026 |
1. Purpose
This SOP outlines the methodology for developing and validating refractive index (RI)-based analytical methods to qualitatively identify or quantitatively determine the concentration or purity of pharmaceutical compounds, primarily for substances
that are colorless or dissolved in aqueous or organic solvents.
2. Scope
This procedure applies to the Analytical Method Development (AMD) department and covers RI-based techniques for raw material qualification, purity profiling, and concentration measurement in liquid formulations, extracts, and solvents used in pharmaceutical analysis.
3. Responsibilities
- Analytical Chemist: Conducts method development and validation trials using RI instrumentation, records observations, and ensures instrument calibration.
- Reviewer: Reviews data for consistency, verifies calibration records, and ensures traceability.
- QA Officer: Ensures regulatory compliance, proper documentation, and audit readiness.
- Head – AMD: Approves the developed and validated method for routine or regulatory application.
4. Accountability
The Head of Analytical Method Development is accountable for the approval, implementation, and maintenance of accurate RI methods in line with regulatory and pharmacopoeial standards.
5. Procedure
5.1 Principle of Refractive Index
- Refractive index (n) is the ratio of the speed of light in vacuum to its speed in a given substance.
- RI varies with concentration, temperature, and wavelength of light; RI measurements can help determine identity or concentration of solutes in solvents.
- Measurement is performed using an Abbe refractometer or digital refractometer at standard temperature (usually 20°C or 25°C).
5.2 Instrumentation and Calibration
- Use calibrated digital or analog refractometers suitable for pharmaceutical applications.
- Calibrate instrument using certified reference standard such as:
- Distilled water (RI = 1.3330 at 20°C)
- Sodium chloride or sucrose solution (known RI)
- Clean prism surfaces thoroughly before and after each use.
- Document instrument ID and calibration in Annexure-1: Instrument Calibration Log.
5.3 Sample Preparation
- Use transparent, colorless, particle-free liquids for accurate RI reading.
- Filter solutions using 0.45 µm membrane if particulate matter is present.
- Maintain temperature control during sample preparation and analysis.
- Document sample batch, concentration, solvent system, and preparation method in Annexure-2: Sample Preparation Log.
5.4 RI Measurement Procedure
- Switch on the refractometer and allow for stabilization as per manufacturer’s instructions.
- Verify instrument calibration using reference standard.
- Place 2–3 drops of test sample onto the prism using a clean glass rod or dropper.
- Close the prism lid gently and allow temperature equilibrium.
- Record RI value displayed by the instrument. For analog, read from scale or via compensation wheel.
- Clean the prism using distilled water followed by ethanol and wipe with lint-free tissue.
- Perform triplicate measurements for each sample and calculate average.
- Document all readings in Annexure-3: RI Observation Log.
5.5 Calculation
Average RI = (RI₁ + RI₂ + RI₃) / 3
Where RI₁, RI₂, and RI₃ are individual replicate readings.
5.6 Method Optimization
- Evaluate:
- Effect of sample temperature (e.g., 20°C vs 25°C)
- Concentration-dependence for quantitative interpretation
- Matrix interference (e.g., solvent effect)
- Develop calibration curve for quantitative analysis using standard solutions (e.g., sucrose, API in solvent).
- Determine linearity range and optimum concentration window.
- Document in Annexure-4: Method Optimization Report.
5.7 Method Validation
- Specificity: Confirm that the sample matrix does not interfere with RI reading.
- Linearity: Plot RI vs. known concentrations. Acceptable R² ≥ 0.999.
- Accuracy: Perform recovery study with known standard solution and compare theoretical RI.
- Precision: Evaluate repeatability across 6 replicates (RSD ≤ 1.0%).
- Robustness: Check reproducibility under ±2°C temperature variation.
- Document validation results in Annexure-5: Validation Summary Report.
6. Abbreviations
- SOP: Standard Operating Procedure
- RI: Refractive Index
- RSD: Relative Standard Deviation
- AMD: Analytical Method Development
7. Documents
- Instrument Calibration Log – Annexure-1
- Sample Preparation Log – Annexure-2
- RI Observation Log – Annexure-3
- Method Optimization Report – Annexure-4
- Validation Summary Report – Annexure-5
8. References
- USP General Chapter <831> – Refractive Index
- EP 2.2.6 – Refractive Index
- ICH Q2(R1) – Validation of Analytical Procedures
- Pharmacopoeia of India – Refractive Index Sections
9. SOP Version
Version: 2.0
10. Approval Section
|
Prepared By |
Checked By |
Approved By |
Signature |
|
|
|
Date |
|
|
|
Name |
|
|
|
Designation |
|
|
|
Department |
|
|
|
11. Annexures
Annexure-1: Instrument Calibration Log
Instrument ID |
Standard Used |
Observed RI |
Acceptance Range |
Status |
Analyst |
RI-102 |
Distilled Water |
1.3331 |
1.3329–1.3331 |
Pass |
Sunita Reddy |
Annexure-2: Sample Preparation Log
Sample Code |
Solvent |
Concentration |
Temperature |
Prepared By |
API-SOL-A |
Water |
1.0% w/v |
25°C |
Rajesh Kumar |
Annexure-3: RI Observation Log
Trial |
RI Value |
Average RI |
Status |
1 |
1.3625 |
1.3624 |
Pass |
2 |
1.3623 |
3 |
1.3624 |
Annexure-4: Method Optimization Report
Parameter |
Variation |
Observation |
Conclusion |
Temperature |
20°C vs 25°C |
RI increased slightly |
Use 25°C consistently |
Annexure-5: Validation Summary Report
Parameter |
Criteria |
Result |
Status |
Accuracy |
±0.001 RI units |
±0.0004 |
Pass |
Precision |
RSD ≤ 1.0% |
0.38% |
Pass |
Linearity |
R² ≥ 0.999 |
0.9992 |
Pass |
Revision History:
Revision Date |
Revision No. |
Details |
Reason |
Approved By |
04/05/2025 |
2.0 |
Expanded method validation and included digital RI instrumentation steps |
Annual SOP Review |
|